- Resources
What Are The Benefits To The Drug Evista?
Pronounced: (ra-LOX-ih-feen)
Uses
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.
Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.
This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen...
Read moreMore information on "What Are The Benefits To The Drug Evista?"
From Our Experts
Evista, New Breast Cancer Treatment
Isn't it ironic? Just a couple of years after paying a fine for the illegal promotion of Evista as a breast cancer prevention drug,... Read more »
Evista (Raloxifene), Breast Cancer and Osteoporosis
For the past few years, most physicians have routinely treated osteoporosis in the same manner. The most commonly used medication class is... Read more »
Evista vs. Breast Cancer?
After intense research, the maker of anti-osteoporosis drug Evista is asking the FDA to approve its use against breast cancer. A related... Read more »
Evista FAQs : Hormone Therapy for Breast Cancer
Q. My family history of breast cancer (both my mother and sister have had it) puts me at high risk of the disease. And now that I'm pushing... Read more »
Update on Evista and Kidney Disease
A new study indicates that raloxifene (sold under the brand name Evista) is safe and effective for treating osteoporosis in postmenopausal... Read more »
From Our Sources
Evista
Source: Breastcancer.org
Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: reduce the risk of... Read more »
FDA panel recommends Evista to cut breast cancer risk
A Food and Drug Administration (FDA) panel has recommended Evista for use in preventing breast cancer. Evista is an osteoporosis medication that has... Read more »
Evista approved for breast cancer
The Food and Drug Administration has approved the osteoporosis med Evista for use in reducing the risk of breast cancer. Evista is approved to treat... Read more »
Generic Evista gets tentative OK
The U.S. Food and Drug Administration has granted tentative approval for a generic form of the commonly used osteoporosis drug Evista. However, the... Read more »
Tamoxifen Prevents More Breast Cancer Cases Than Evista
Researchers say the drug tamoxifen prevented more cases of breast cancer after 7 years than the osteoporosis drug Evista, though Evista had fewer... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
